CDKN2A and glioblastoma: A recent study analyzed genomic sequencing data from the temporally separated tumor pairs of 304 adult patients and found acquired CDKN2A deletions were associated with increased cell proliferation at tumor recurrence, suggesting mutations in cell cycle signaling might be late in temporal order in GBM development [32].